184 related articles for article (PubMed ID: 27784762)
1. DNA-fragmentation is a source of bactericidal activity against Pseudomonas aeruginosa.
Bhongir RK; Kasetty G; Papareddy P; Mörgelin M; Herwald H; Egesten A
Biochem J; 2017 Feb; 474(3):411-425. PubMed ID: 27784762
[TBL] [Abstract][Full Text] [Related]
2. NET formation induced by Pseudomonas aeruginosa cystic fibrosis isolates measured as release of myeloperoxidase-DNA and neutrophil elastase-DNA complexes.
Yoo DG; Floyd M; Winn M; Moskowitz SM; Rada B
Immunol Lett; 2014 Aug; 160(2):186-94. PubMed ID: 24670966
[TBL] [Abstract][Full Text] [Related]
3. The neutrophil-recruiting chemokine GCP-2/CXCL6 is expressed in cystic fibrosis airways and retains its functional properties after binding to extracellular DNA.
Jovic S; Linge HM; Shikhagaie MM; Olin AI; Lannefors L; Erjefält JS; Mörgelin M; Egesten A
Mucosal Immunol; 2016 Jan; 9(1):112-23. PubMed ID: 25993443
[TBL] [Abstract][Full Text] [Related]
4. Antimicrobial efficacy of tobramycin polymeric nanoparticles for Pseudomonas aeruginosa infections in cystic fibrosis: formulation, characterisation and functionalisation with dornase alfa (DNase).
Deacon J; Abdelghany SM; Quinn DJ; Schmid D; Megaw J; Donnelly RF; Jones DS; Kissenpfennig A; Elborn JS; Gilmore BF; Taggart CC; Scott CJ
J Control Release; 2015 Jan; 198():55-61. PubMed ID: 25481442
[TBL] [Abstract][Full Text] [Related]
5. DNA is an antimicrobial component of neutrophil extracellular traps.
Halverson TW; Wilton M; Poon KK; Petri B; Lewenza S
PLoS Pathog; 2015 Jan; 11(1):e1004593. PubMed ID: 25590621
[TBL] [Abstract][Full Text] [Related]
6. Modifications of Pseudomonas aeruginosa cell envelope in the cystic fibrosis airway alters interactions with immune cells.
Hill PJ; Scordo JM; Arcos J; Kirkby SE; Wewers MD; Wozniak DJ; Torrelles JB
Sci Rep; 2017 Jul; 7(1):4761. PubMed ID: 28684799
[TBL] [Abstract][Full Text] [Related]
7. Resistance of the antibacterial agent ceragenin CSA-13 to inactivation by DNA or F-actin and its activity in cystic fibrosis sputum.
Bucki R; Sostarecz AG; Byfield FJ; Savage PB; Janmey PA
J Antimicrob Chemother; 2007 Sep; 60(3):535-45. PubMed ID: 17584802
[TBL] [Abstract][Full Text] [Related]
8. Neutrophil extracellular trap (NET)-mediated killing of Pseudomonas aeruginosa: evidence of acquired resistance within the CF airway, independent of CFTR.
Young RL; Malcolm KC; Kret JE; Caceres SM; Poch KR; Nichols DP; Taylor-Cousar JL; Saavedra MT; Randell SH; Vasil ML; Burns JL; Moskowitz SM; Nick JA
PLoS One; 2011; 6(9):e23637. PubMed ID: 21909403
[TBL] [Abstract][Full Text] [Related]
9. Secreted Phosphatase and Deoxyribonuclease Are Required by Pseudomonas aeruginosa To Defend against Neutrophil Extracellular Traps.
Wilton M; Halverson TWR; Charron-Mazenod L; Parkins MD; Lewenza S
Infect Immun; 2018 Sep; 86(9):. PubMed ID: 29967090
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of Rhesus Theta-Defensin-1 in Experimental Models of Pseudomonas aeruginosa Lung Infection and Inflammation.
Bensman TJ; Jayne JG; Sun M; Kimura E; Meinert J; Wang JC; Schaal JB; Tran D; Rao AP; Akbari O; Selsted ME; Beringer PM
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559270
[TBL] [Abstract][Full Text] [Related]
11. Glucosylceramide Critically Contributes to the Host Defense of Cystic Fibrosis Lungs.
Kovacic B; Sehl C; Wilker B; Kamler M; Gulbins E; Becker KA
Cell Physiol Biochem; 2017; 41(3):1208-1218. PubMed ID: 28427052
[TBL] [Abstract][Full Text] [Related]
12. Expression and antimicrobial function of bactericidal permeability-increasing protein in cystic fibrosis patients.
Aichele D; Schnare M; Saake M; Röllinghoff M; Gessner A
Infect Immun; 2006 Aug; 74(8):4708-14. PubMed ID: 16861658
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of high-mobility group box 1 protein (HMGB1) enhances bacterial clearance and protects against Pseudomonas Aeruginosa pneumonia in cystic fibrosis.
Entezari M; Weiss DJ; Sitapara R; Whittaker L; Wargo MJ; Li J; Wang H; Yang H; Sharma L; Phan BD; Javdan M; Chavan SS; Miller EJ; Tracey KJ; Mantell LL
Mol Med; 2012 May; 18(1):477-85. PubMed ID: 22314397
[TBL] [Abstract][Full Text] [Related]
14. P-113D, an antimicrobial peptide active against Pseudomonas aeruginosa, retains activity in the presence of sputum from cystic fibrosis patients.
Sajjan US; Tran LT; Sole N; Rovaldi C; Akiyama A; Friden PM; Forstner JF; Rothstein DM
Antimicrob Agents Chemother; 2001 Dec; 45(12):3437-44. PubMed ID: 11709321
[TBL] [Abstract][Full Text] [Related]
15. Agmatine accumulation by Pseudomonas aeruginosa clinical isolates confers antibiotic tolerance and dampens host inflammation.
McCurtain JL; Gilbertsen AJ; Evert C; Williams BJ; Hunter RC
J Med Microbiol; 2019 Mar; 68(3):446-455. PubMed ID: 30688634
[TBL] [Abstract][Full Text] [Related]
16. Rhesus θ-defensin-1 (RTD-1) exhibits in vitro and in vivo activity against cystic fibrosis strains of Pseudomonas aeruginosa.
Beringer PM; Bensman TJ; Ho H; Agnello M; Denovel N; Nguyen A; Wong-Beringer A; She R; Tran DQ; Moskowitz SM; Selsted ME
J Antimicrob Chemother; 2016 Jan; 71(1):181-8. PubMed ID: 26433781
[TBL] [Abstract][Full Text] [Related]
17. Pseudomonas-infected cystic fibrosis patient sputum inhibits the bactericidal activity of normal human serum.
Schiller NL; Millard RL
Pediatr Res; 1983 Sep; 17(9):747-52. PubMed ID: 6413945
[TBL] [Abstract][Full Text] [Related]
18. Aerosolized bovine lactoferrin reduces neutrophils and pro-inflammatory cytokines in mouse models of Pseudomonas aeruginosa lung infections.
Valenti P; Frioni A; Rossi A; Ranucci S; De Fino I; Cutone A; Rosa L; Bragonzi A; Berlutti F
Biochem Cell Biol; 2017 Feb; 95(1):41-47. PubMed ID: 28129511
[TBL] [Abstract][Full Text] [Related]
19. Neutrophil extracellular traps are present in the airways of ENaC-overexpressing mice with cystic fibrosis-like lung disease.
Tucker SL; Sarr D; Rada B
BMC Immunol; 2021 Jan; 22(1):7. PubMed ID: 33478382
[TBL] [Abstract][Full Text] [Related]
20. Antibacterial and anti-inflammatory activity of a temporin B peptide analogue on an in vitro model of cystic fibrosis.
Bezzerri V; Avitabile C; Dechecchi MC; Lampronti I; Borgatti M; Montagner G; Cabrini G; Gambari R; Romanelli A
J Pept Sci; 2014 Oct; 20(10):822-30. PubMed ID: 25201563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
